Richard Kay - Founder and Industry Thought Leader
Professional Overview
Richard Kay is a respected founder, statistician, and industry expert with over 40 years of experience advancing the field of biostatistics. As the Founder of RK STATISTICS and an Honorary Visiting Professor at Cardiff University, he leverages his exceptional technical competencies and deep industry knowledge to drive innovation and shape best practices.
Experience Summary
Current Role
As the Founder of RK STATISTICS since 2005, Richard is responsible for providing high-level statistical consulting, leading research initiatives, and mentoring the next generation of biostatisticians. Under his guidance, the firm has become a trusted partner to pharmaceutical and healthcare organizations, delivering impactful data-driven solutions that have improved clinical trial outcomes and accelerated product development.
Career Progression
Prior to founding his own venture, Richard held several influential roles, including Vice President and Worldwide Head of Biostatistics and Programming at PAREXEL International, where he oversaw a global team and was instrumental in expanding the company's service offerings. He also served as the Managing Director and Owner of SCubed, a specialized biostatistics firm, and as a Lecturer in the Department of Probability and Statistics at the University of Sheffield.
Academic Background
Richard holds a strong academic background, having earned a distinguished reputation in the field. He currently serves as an Honorary Visiting Professor at Cardiff University, where he collaborates with researchers and shares his expertise through guest lectures and advisory roles.
Areas of Expertise
- Advanced statistical modeling and analysis
- Clinical trial design and execution
- Data management and reporting
- Regulatory compliance and submissions
- Team leadership and project management
Professional Impact
Throughout his career, Richard has made significant contributions to the advancement of biostatistics. He has led numerous high-profile projects, including the development of novel statistical methodologies that have been widely adopted by the pharmaceutical industry. Richard's thought leadership and industry contributions have been recognized through his appointment as an Honorary Visiting Professor and his participation in various industry associations and conferences.
Conclusion
With his exceptional technical expertise, industry knowledge, and visionary leadership, Richard Kay continues to shape the field of biostatistics and drive meaningful impact for his clients and the broader healthcare community. As he focuses on expanding the reach of RK STATISTICS and fostering the next generation of statistical experts, Richard remains committed to advancing the use of data-driven insights to improve patient outcomes and accelerate medical innovation.
